NEW YORK (GenomeWeb) – Great Basin Scientific today announced it has submitted its Shiga Toxin Direct Test to the US Food and Drug Administration for 510(k) review. 

The submission follows the successful completion of a clinical trial by the Salt Lake City-based firm that met all of its clinical objectives, Great Basin said. If cleared, the test will be the only stand-alone molecular test for detecting Shiga toxin-producing E. coli and the serotype O157 directly from a patient specimen, it added. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Sponsored by

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.